Cornell documents first molecularly confirmed feline Marfan cases

Cornell University investigators say they’ve documented the first known molecularly characterized cases of Marfan syndrome in domestic cats, a finding that extends a well-known human connective tissue disorder into feline medicine. In a Scientific Reports paper published September 19, 2026, the team described littermate cats Gary and Shaggy, whose long limbs, bilateral lens luxation, and aortic root dilation led clinicians to suspect Marfan syndrome and pursue genetic testing. (nature.com)

The discovery matters partly because Marfan syndrome has been extensively studied in people, but spontaneous animal models are uncommon. In humans, the disorder is typically linked to pathogenic variants in FBN1, and cardiovascular complications involving the aorta are central to long-term risk. Cornell said this was the first documented feline case, bringing together specialists in cardiology, ophthalmology, pathology, and genetics from Cornell, Ghent University, the University of Pennsylvania, and the Schwarzman Animal Medical Center. (nature.com)

According to the paper, whole-genome sequencing identified a homozygous splice-region variant in FBN1 located three bases upstream of exon 22. The authors reported that the variant was absent from a comparison cohort of more than 1,000 cats. Oxford Nanopore cDNA sequencing showed exon 22 skipping in 73% of transcripts, affecting a domain important for fibrillin-1 folding and stability. Histopathology of the ascending aorta from one affected cat also showed disrupted and fractured elastic fiber tendrils, changes the authors said were consistent with impaired fibrillin-1 function and with medial degeneration seen in human Marfan syndrome. (nature.com)

One nuance in the report is that both cats carried two altered copies of FBN1, whereas human Marfan syndrome is usually autosomal dominant and often appears with a single altered copy. Cornell’s news release said the feline variant did not completely shut down the gene. Instead, it partially disrupted splicing, leaving some normal transcript production intact. That “leaky” effect may help explain how the cats survived into adulthood despite homozygosity for a disease-associated variant. Senior author Dr. Jacquelyn Evans said the findings may help veterinarians recognize similar cases in the future. (vet.cornell.edu)

Industry reaction appears to be centered less on immediate practice change and more on diagnostic awareness and comparative medicine. Cornell framed the cases as an example of collaboration between pet parents and veterinary specialists, and as part of the Baker Institute’s long-running comparative approach. The paper itself also positions the cases as a rare spontaneous animal model that could offer insight into the molecular basis of Marfan syndrome across species. (vet.cornell.edu)

Why it matters: For practicing veterinarians, the practical takeaway is that Marfan syndrome now belongs on the list of possible explanations when a cat presents with a recognizable triad of disproportionate limb length, lens instability or luxation, and aortic root enlargement. That doesn’t mean the syndrome will be common, and the current report is limited to two siblings. Still, it gives clinicians a published framework for referral, imaging, ophthalmic evaluation, and genetic consultation in unusual multisystem cases. It may also shape conversations with breeders and pet parents if more familial cases are recognized. This is an inference from the reported phenotype and gene finding, but it’s a reasonable one grounded in the study’s cross-disciplinary diagnostic workup. (nature.com)

The finding may also be relevant for veterinary research. Because spontaneous animal models of Marfan syndrome are rare, these cases could help comparative investigators study how altered fibrillin-1 affects the eye, skeleton, and aorta in a naturally occurring setting rather than an engineered model. That won’t change day-to-day feline practice overnight, but it could sharpen future understanding of connective tissue disease mechanisms and, eventually, diagnostic tools. (nature.com)

What to watch: The next step is whether other veterinary centers begin reporting similar cats, whether the FBN1 variant or related variants turn up in broader feline genomic databases, and whether any research group develops a validated clinical genetic test for suspected feline Marfan syndrome. For now, the evidence base is a single peer-reviewed case report involving two littermates, published in September 2026. (nature.com)